Xenon Pharmaceuticals (XENE) AGM 2024 summary

Opening remarks and agenda

• Meeting held virtually with voting conducted online via the Lumi Virtual Platform operated by Equiniti.

• Attendees included board members, executives, and shareholders, with procedures for questions and voting explained at the outset.

• The meeting was functional in format, focused on legal requirements, with no corporate presentation.

• Quorum was confirmed as present, meeting the bylaw requirement of at least 33 1/3% of shares represented.

Financial performance review

• Financial statements and auditor's report for the year ended December 31, 2023, were presented and made available to shareholders.

• No questions were raised regarding the financial statements or auditor's report.

Board and executive committee updates

• Eight nominees for the Board of Directors were presented and consented to act as directors.

• Simon Pimstone concluded his tenure as Chair, with Dawn Svoronos assuming the role.

• Recognition was given to long-serving board members Mohammad Azab and Simon Pimstone for their contributions.